Lincotrade & Associates Unit to Acquire Opto-Pharm in SG$17 Million Deal; Shares Down 3%
MT Newswires
Apr 29
Lincotrade & Associates (SGX:BFT) 50% owned subsidiary, Linc-A, signed a non-binding term sheet to acquire 100% of Opto-Pharm for SG$17 million, according to a Tuesday filing with the Singapore Exchange.
Shares of the industrial fitting-out services provider were down over 3% in Wednesday trading.
Opto-Pharm is involved in the manufacturing and distribution of pharmaceutical ophthalmic and other solutions and owns properties in Tuas Avenue.
The move is part of the company's strategy to expand its operations and support services.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.